Diagnostic and prognostic value of glypican-3 as a biomarker in the diagnosis of hepatocellular carcinoma in Egyptian patients with hepatitis C virus-related cirrhosis before and after interventional treatment

Conclusion GPC-3 has better diagnostic performance than alfa feto protein (AFP) in differentiating HCC from other groups and giving better evaluation in response to treatment in different HCC groups in addition to a combination of GPC-3 and AFP among HCC groups (radiofrequency and transarterial chemoembolization) slightly increases the sensitivity of AFP.
Source: Egyptian Liver Journal - Category: Gastroenterology Tags: Original articles Source Type: research